Revised Multiple Myeloma International Staging System (R-ISS) - MDCalc
WEBThe Revised multiple Myeloma International Staging System (ISS) stages multiple myeloma patients based on genetics and routine lab values in conjunction with the original ISS.
Multiple Myeloma International Staging System (ISS) - MDCalc
WEBThe Multiple Myeloma International Staging System (ISS) prognosticates the severity of multiple myeloma based on routinely obtained lab values.
International Staging System for Multiple Myeloma | The IMF
WEBThe International Staging System (ISS) and Revised ISS (R-ISS) are the two most up-to-date prognostic staging systems for multiple myeloma. See details. In 2005, a new staging system was developed by the IMF's research division, …
Multiple Myeloma Stages - American Cancer Society
WEBMultiple myeloma is staged using the Revised International Staging System (RISS), which is based on 4 factors: The amount of albumin in the blood. The amount of beta-2-microglobulin in the blood. The amount of LDH in the blood. The specific gene abnormalities (cytogenetics) of the cancer.
Multiple Myeloma Prognosis (ISS) - QxMD
WEBBased exclusively on the beta 2 microglobulin and albumin levels at diagnosis, the ISS relies on simple and available lab parameters, and thus may be more objective than previous staging systems, including the Salmon-Durie system based on clinical variables.
Diagnosing Multiple Myeloma and Stages 1, 2, 3
WEBTo describe the stage, doctors use the International Staging System (ISS) and the Revised International Staging System (R-ISS). These scoring systems get information from blood tests. The tests measure levels of beta 2 microglobulin (β2M), albumin, and lactate dehydrogenase.
Multiple Myeloma | Staging Multiple Myeloma | LLS
WEBDoctors use one of two staging systems: the Durie-Salmon Staging System or the newer International Staging System. Doctors also use the terms smoldering myeloma or asymptomatic myeloma to describe the disease when its presence is minimal with little evidence of progression.
Revised International Staging System for Multiple Myeloma: A …
WEBAug 3, 2015 · The ISS score, defined in 2005, identifies three patient groups with different prognoses; the median overall survival (OS) was 62 months in the ISS stage I, 44 months in the ISS stage II, and 29 months in the ISS stage III groups (P < .001). 2
Multiple Myeloma Stages | International Myeloma Foundation
WEBJul 20, 2021 · Multiple myeloma stages range from asymptomatic to relapsed/refractory. Learn about staging criteria for multiple myeloma and the phases of the disease.
Revised International Staging System for Multiple Myeloma: A …
WEBSep 10, 2015 · The R-ISS allowed a clear identification of the following three survival patterns through a simplified rule: R-ISS stage I includes ISS stage I, no high-risk CA, and normal LDH; R-ISS stage III includes ISS stage III with high-risk CA and/or high LDH levels; R-ISS stage II includes all the remaining conditions.
Skip to content